ELOXX PHARMACEUTICALS INC (ELOX) Institutional Ownership Changes & 13F Activity
ELOXX PHARMACEUTICALS INC (ELOX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Nantahala Capital Management, Llc, Ecor1 Capital, Llc, Samsara Biocapital, Llc, Siren, L.L.C., and Aberdeen Group Plc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, Llc | Buy | +400,000 | — | 400,000 | $5.55M | Q2 2026 | Aug 19, 2026 |
| Stonepine Capital Management, Llc | Buy | +397,160 | — | 397,160 | $5.51M | Q2 2026 | Aug 17, 2026 |
| Ecor1 Capital, Llc | Buy | +400,000 | — | 400,000 | $5.55M | Q2 2026 | Aug 14, 2026 |
| Samsara Biocapital, Llc | Buy | +400,000 | — | 400,000 | $5.55M | Q2 2026 | Aug 14, 2026 |
| Seven Grand Managers, Llc | Buy | +10,000 | — | 10,000 | $138.80K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +126 | — | 126 | $1.75K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +98 | — | 98 | $1.00K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +12 | — | 12 | $167.00 | Q2 2026 | Aug 14, 2026 |
| Siren, L.L.C. | Buy | +400,000 | — | 400,000 | $5.55M | Q2 2026 | Aug 13, 2026 |
| Vanguard Capital Management Llc | Buy | +78,680 | — | 78,680 | $1.09M | Q2 2026 | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +10,602 | — | 10,602 | $147.16K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Buy | +1,544 | — | 1,544 | $21.43K | Q2 2026 | Aug 13, 2026 |
| Vanguard Global Advisers, Llc | Buy | +718 | — | 718 | $9.97K | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Buy | +637 | — | 637 | $8.84K | Q2 2026 | Aug 13, 2026 |
| Altshuler Shaham Ltd | Buy | +25 | — | 25 | $347.00 | Q2 2026 | Aug 12, 2026 |
| Point Nemo Capital, Llc | Buy | +1 | — | 1 | $14.00 | Q2 2026 | Aug 07, 2026 |
| Citigroup Inc | Buy | +4 | — | 4 | $56.00 | Q2 2026 | Aug 03, 2026 |
| Aberdeen Group Plc | Buy | +400,000 | — | 400,000 | $5.55M | Q2 2026 | Jul 31, 2026 |
| Towne Trust Company, N.A | Buy | +5 | — | 5 | $69.00 | Q2 2026 | Jul 30, 2026 |
| Pioneer Family Office, Llc | Buy | +96 | — | 96 | $1.33K | Q2 2026 | Jul 28, 2026 |
| Sbi Securities Co., Ltd. | Buy | +2 | — | 2 | $28.00 | Q2 2026 | Jul 23, 2026 |
| Activest Wealth Management | Buy | +4 | — | 4 | $56.00 | Q2 2026 | Jul 16, 2026 |
Frequently asked questions about ELOX activity
Which institutional owners are buying ELOX?
Institutional owners buying ELOX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ELOX activity?
"Buy" means an investor increased their reported position in ELOX compared to the prior reporting period. This reflects growing exposure to ELOXX PHARMACEUTICALS INC (ELOX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ELOX increasing?
Institutional interest in ELOX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.